JAMA has issued an Expression of Concern about a 2005 study of whether two different types of vitamin B could prevent broken hips in people who’d suffered strokes.
The original study concluded:
In this Japanese population with a high baseline fracture risk, combined treatment with folate and vitamin B12 is safe and effective in reducing the risk of a hip fracture in elderly patients following stroke.
Here’s the notice for the study, “Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial:” Continue reading JAMA vitamin-hip fracture study earns Expression of Concern for integrity issues
The Journal of Bone and Joint Surgery has retracted a 2012 paper because of ethical violations, initially flagged by the journal in 2013.
The study, which examined the use of autologous cell therapy in treating Achilles tendinosis, claimed in its abstract to have “conducted a randomized, double-blind study on forty Achilles tendons in thirty-two patients.” Apparently, though, it wasn’t actually a clinical trial but was somehow, according to the retraction notice, “misclassified” as such “in error.”
The problem was originally flagged by the UK’s Medicines and Healthcare products Regulatory Agency, which wrote the journal to tell them that it hadn’t granted ethical approval for the study, as we reported in 2013. At the time, there was a question about whether the lead author had retained records of the results, which is addressed in the retraction notice, signed by editor-in-chief Marc F. Swiontkowski and editor-in-Chief Emeritus Vernon T. Tolo: Continue reading Clinical trial of Achilles tendon therapy retracted for not actually being a clinical trial
BioMed Central is retracting 43 papers, following their investigation into 50 papers that raised suspicions of fake peer review, possibly involving third-party companies selling the service.
In November 2014 we wrote about fake peer reviews for Nature; at that point there had been about 110 retractions across several journals. The addition of 16 retractions by Elsevier for the same reason, and today’s 43 from BMC, brings retractions resulting from the phenomenon up to about 170.
BMC has also contacted institutions regarding 60 additional papers that were rejected for publication, but seem to be part of the same kind of scam. Regarding the third-party agents, BMC senior editor of scientific integrity Elizabeth Moylan writes: Continue reading BioMed Central retracting 43 papers for fake peer review
Rehabilitation Research and Practice has retracted a 2012 review article on stiff big toes.
The article, “Therapeutic Management of the Hallux Rigidus,” came from a group in India. According to the abstract: Continue reading “Substantial flaws” trip up big toe paper
Climacteric is retracting a 2013 article by a group of researchers in Seoul who used data from a paper by another duo of Korean scientists also published in, you guessed it, Climacteric.
The paper, “Different bone mineral density in cervical and endometrial cancer,” came from a group of Soonchunhyang University and was published online late last year. It purported to look at the association between gynecologic cancers and bone mineral density: Continue reading Bone-headed move? Authors of cancer-skeleton paper copy from paper in same journal
Another busy week at Retraction Watch, beginning with a story we broke about faked HIV vaccine results that was picked up by the Des Moines Register and other outlets. Here’s what was happening elsewhere on the web: Continue reading Weekend reads: Snarky acknowledgement sections, journal editors on fraud
The Journal of Bone and Joint Surgery has issued an expression of concern about a paper whose authors may not have obtained proper ethical clearance.
Here’s the notice, signed by editor in chief Vernon Tolo: Continue reading Lack of ethical clearance prompts expression of concern from bone journal
In July, we reported on the unfortunate math of Harish Hosalkar, a San Diego orthopedic surgeon who was at the center of an institutional investigation into the integrity of his data, two lawsuits and three retractions.
At the time, we were waiting on the third retraction, in the journal Orthopedic Reviews. It has now arrived.
The article was titled “Open reduction and internal fixation of displaced clavicle fractures in adolescents,” and Hosalkar wrote it with Gaurav Parikh, James D. Bomar and Bernd Bittersohl. Continue reading Third retraction appears for orthopedic surgeon involved in investigation, lawsuits
The University of Tokyo panel investigating the work of a former professor there, Shigeaki Kato, has recommended the retraction of 43 of his group’s articles, according to a report in the Asahi Shimbun newspaper.
If the papers are indeed retracted, Kato, who already has at least five articles subject to an expression of concern and five retractions, would be fifth on the list of most retractions for a single author, by our unofficial tally. His fellow countryman, Yoshitaka Fujii, continues to hold the lead at what appears to be 183, followed by Joachim Boldt (~89), John Darsee (~83), and Diederik Stapel, at 53. [See note at end.]
The Asahi report quotes Kato — who has received some $20 million in government funding for his work — as acknowledging problems with the data in his studies: Continue reading Tokyo panel calls for retraction of 43 Kato papers
Three retractions, two lawsuits, one institutional inquiry. That’s not the kind of math anyone likes to do — but it’s the tally for Harish Hosalkar, a San Diego surgeon specializing in pediatric orthopedics.
Hosalkar became embroiled in a messy affair after problems surfaced in data he had published while at Rady Children’s Hospital — a facility he left under a cloud of recriminations. More on that in a bit. Continue reading Three retractions, two lawsuits, one institutional inquiry for San Diego orthopedic surgeon